Pruitt RE - Search Results

1

Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's Esophagus.

Wolf WA, Pasricha S, Cotton C, Li N, Triadafilopoulos G, Muthusamy VR, Chmielewski GW, Corbett FS, Camara DS, Lightdale CJ, Wolfsen H, Chang KJ, Overholt BF, Pruitt RE, Ertan A, Komanduri S, Infantolino A, Rothstein RI, Shaheen NJ. Wolf WA, et al. Among authors: pruitt re. Gastroenterology. 2015 Dec;149(7):1752-1761.e1. doi: 10.1053/j.gastro.2015.08.048. Epub 2015 Aug 29. Gastroenterology. 2015. PMID: 26327132 Free PMC article.

2

Effects of the Learning Curve on Efficacy of Radiofrequency Ablation for Barrett's Esophagus.

Pasricha S, Cotton C, Hathorn KE, Li N, Bulsiewicz WJ, Wolf WA, Muthusamy VR, Komanduri S, Wolfsen HC, Pruitt RE, Ertan A, Chmielewski GW, Shaheen NJ. Pasricha S, et al. Among authors: pruitt re. Gastroenterology. 2015 Oct;149(4):890-6.e2. doi: 10.1053/j.gastro.2015.06.012. Epub 2015 Jun 25. Gastroenterology. 2015. PMID: 26116806 Free PMC article.

3

Effects of preceding endoscopic mucosal resection on the efficacy and safety of radiofrequency ablation for treatment of Barrett's esophagus: results from the United States Radiofrequency Ablation Registry.

Li N, Pasricha S, Bulsiewicz WJ, Pruitt RE, Komanduri S, Wolfsen HC, Chmielewski GW, Corbett FS, Chang KJ, Shaheen NJ. Li N, et al. Among authors: pruitt re. Dis Esophagus. 2016 Aug;29(6):537-43. doi: 10.1111/dote.12386. Epub 2015 Jun 30. Dis Esophagus. 2016. PMID: 26121935 Free PMC article.

4

Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease: A randomized, sham-controlled trial.

Rothstein R, Filipi C, Caca K, Pruitt R, Mergener K, Torquati A, Haber G, Chen Y, Chang K, Wong D, Deviere J, Pleskow D, Lightdale C, Ades A, Kozarek R, Richards W, Lembo A. Rothstein R, et al. Gastroenterology. 2006 Sep;131(3):704-12. doi: 10.1053/j.gastro.2006.07.004. Gastroenterology. 2006. PMID: 16952539 Clinical Trial.

5

Radiofrequency ablation of Barrett's esophagus: outcomes of 429 patients from a multicenter community practice registry.

Lyday WD, Corbett FS, Kuperman DA, Kalvaria I, Mavrelis PG, Shughoury AB, Pruitt RE. Lyday WD, et al. Among authors: pruitt re. Endoscopy. 2010 Apr;42(4):272-8. doi: 10.1055/s-0029-1243883. Epub 2010 Feb 9. Endoscopy. 2010. PMID: 20146164

6

Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry.

Ganz RA, Overholt BF, Sharma VK, Fleischer DE, Shaheen NJ, Lightdale CJ, Freeman SR, Pruitt RE, Urayama SM, Gress F, Pavey DA, Branch MS, Savides TJ, Chang KJ, Muthusamy VR, Bohorfoush AG, Pace SC, DeMeester SR, Eysselein VE, Panjehpour M, Triadafilopoulos G; U.S. Multicenter Registry. Ganz RA, et al. Among authors: pruitt re. Gastrointest Endosc. 2008 Jul;68(1):35-40. doi: 10.1016/j.gie.2007.12.015. Epub 2008 Mar 19. Gastrointest Endosc. 2008. PMID: 18355819

7

Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group.

Hanauer SB, Robinson M, Pruitt R, Lazenby AJ, Persson T, Nilsson LG, Walton-Bowen K, Haskell LP, Levine JG. Hanauer SB, et al. Gastroenterology. 1998 Sep;115(3):525-32. doi: 10.1016/s0016-5085(98)70131-3. Gastroenterology. 1998. PMID: 9721148 Clinical Trial.

8

Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis: A Randomized, Placebo-controlled Clinical Trial.

Gordon GL, Zakko S, Murthy U, Sedghi S, Pruitt R, Barrett AC, Bortey E, Paterson C, Forbes WP, Lichtenstein GR. Gordon GL, et al. J Clin Gastroenterol. 2016 Apr;50(4):318-25. doi: 10.1097/MCG.0000000000000414. J Clin Gastroenterol. 2016. PMID: 26368296 Clinical Trial.

9

Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.

Pruitt R, Hanson J, Safdi M, Wruble L, Hardi R, Johanson J, Koval G, Riff D, Winston B, Cross A, Doty P, Johnson LK. Pruitt R, et al. Am J Gastroenterol. 2002 Dec;97(12):3078-86. doi: 10.1111/j.1572-0241.2002.07103.x. Am J Gastroenterol. 2002. PMID: 12492193 Clinical Trial.

10

Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.

Scherl EJ, Pruitt R, Gordon GL, Lamet M, Shaw A, Huang S, Mareya S, Forbes WP. Scherl EJ, et al. Am J Gastroenterol. 2009 Jun;104(6):1452-9. doi: 10.1038/ajg.2009.83. Epub 2009 Apr 21. Am J Gastroenterol. 2009. PMID: 19491859 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page